The Patent Finder

Contrafect Corporation

Also on record
Records under this name other than the patents Contrafect Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Contrafect Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,524,046Biofilm Prevention, Disruption and Treatment with Bacteriophage Lysin
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,639,370Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,246,928Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,144,845Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,491,245Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,773,140Gram-Negative Lysin-Antimicrobial Peptide (AMP) Polypeptide Constructs, Lysins, Isolated Polynucleotides Encoding Same and Uses Thereof in Human Serum
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,121,568Identification of Lysins and Derivatives Thereof with Bactericidal Activity Against Pseudomonas Aeruginosa
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,413,334Lysin Polypeptides Active Against Gram-Negative Bacteria
Formerly held
Lapsed on the fee record
Ended Aug 16, 2026 · High confidence
Lapsed on the fee recordEnded Aug 16, 2026High confidence
US 11,357,833Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
Lapsed on the fee record
Ended Jun 14, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2026USPTO record
US 9,889,181Bacteriophage Lysin and Antibiotic Combinations Against Gram Positive Bacteria
Formerly held
Lapsed on the fee record
Ended Feb 13, 2026 · Low confidence
Lapsed on the fee recordEnded Feb 13, 2026Low confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited